1. Clément, B., Hofman, P., Desille, M., & Dagher, G. (2017). Réalités industrielles. La normalisation des techniques d’ingénierie en recherche biomédicale: l’exemple des centres de ressources biologiques. Annales des Mines, 2, 24–28.
2. Clément, B., Yuille, M., Zaltoukal, K., Wichmann, H. E., Anton, G., Parodi, B., et al. (2014). EU-US expert group on cost recovery in biobanks. Public biobanks: Calculation and recovery of costs. Science Translational Medicine, 6(261), 261fs45.
3. Cooreman, A., Bravo, E., van Gool, A. J., Puchois, P., Roehrl, H. A., & Hofman, P. (2017). Traceability and transparency should be mandatory for all human biospecimens. Applied Clinical Trials, 2, 1–7.
4. Doucet, M., Becker, K. F., Björkman, J., Bonnet, J., Clément, B., Daidone, M. G., et al. (2016). Quality matters: 2016 annual conference of the National Infrastructures for biobanking. Biopreservation and Biobanking, 15, 270–276.
5. Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015). The economics of reproducibility in preclinical research. PLoS Biology, 13(6), e1002165.